Gene · 4299
Papers2,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential cofactor dependencies define distinct types of human enhancers. | Nature | 2022 | 35650434 | PubTator, text mining | PubMed |
| Nrf2 Overexpression Decreases Vincristine Chemotherapy Sensitivity Through the PI3K-AKT Pathway in Adult B-Cell Acute Lymphoblastic Leukemia. | Front Oncol | 2022 | 35646695 | PubTator, text mining | PubMed |
| Relapsed acute lymphoblastic leukaemia after allogeneic stem cell transplantation: a therapeutic dilemma challenging the armamentarium of immunotherapies currently available (case reports). | Ther Adv Hematol | 2022 | 35646299 | PubTator, text mining | PubMed |
| Malaria parasites release vesicle subpopulations with signatures of different destinations. | EMBO Rep | 2022 | 35642585 | PubTator, text mining | PubMed |
| How Placenta Promotes the Successful Reproduction in High-Altitude Populations: A Transcriptome Comparison between Adaptation and Acclimatization. | Mol Biol Evol | 2022 | 35642306 | PubTator, text mining | PubMed |
| Bone Marrow Aging and the Leukaemia-Induced Senescence of Mesenchymal Stem/Stromal Cells: Exploring Similarities. | J Pers Med | 2022 | 35629139 | PubTator, text mining | PubMed |
| Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation. | Int J Mol Sci | 2022 | 35628648 | PubTator, text mining | PubMed |
| Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment. | Cancers (Basel) | 2022 | 35626170 | PubTator, text mining | PubMed |
| Transcription Pause and Escape in Neurodevelopmental Disorders. | Front Neurosci | 2022 | 35615272 | PubTator, text mining | PubMed |
| The 3' Pol II pausing at replication-dependent histone genes is regulated by Mediator through Cajal bodies' association with histone locus bodies. | Nat Commun | 2022 | 35614107 | PubTator, text mining | PubMed |
| Bisphenol a exposure decreases learning ability through the suppression of mitochondrial oxidative phosphorylation in the hippocampus of male mice. | Food Chem Toxicol | 2022 | 35598803 | PubTator, text mining | PubMed |
| Pediatric Leukemia From an Orthopedic Perspective: A Case of Acute Lymphoblastic Leukemia Initially Managed as Septic Hip With Osteomyelitis. | Cureus | 2022 | 35573545 | PubTator, text mining | PubMed |
| The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements via Epigenetic Modification. | Front Pharmacol | 2022 | 35571127 | PubTator, text mining | PubMed |
| Arginine Methyltransferase PRMT7 Deregulates Expression of RUNX1 Target Genes in T-Cell Acute Lymphoblastic Leukemia. | Cancers (Basel) | 2022 | 35565298 | PubTator, text mining | PubMed |
| The Social Norm of Hematopoietic Stem Cells and Dysregulation in Leukemia. | Int J Mol Sci | 2022 | 35563454 | PubTator, text mining | PubMed |
| miRNAs in Lymphocytic Leukaemias-The miRror of Drug Resistance. | Int J Mol Sci | 2022 | 35563051 | PubTator, text mining | PubMed |
Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T Cells. | Front Immunol | 2022 | 35558072 | PubTator, text mining | PubMed |
| A bioactive phlebovirus-like envelope protein in a hookworm endogenous virus. | Sci Adv | 2022 | 35544562 | PubTator, text mining | PubMed |
| Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia. | Int J Clin Oncol | 2022 | 35536524 | PubTator, text mining | PubMed |
| P-TEFb is degraded by Siah1/2 in quiescent cells. | Nucleic Acids Res | 2022 | 35524561 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4299/papers?page=20